European Journal of Cancer
Volume 36, Issue 17 , Pages 2221-2226, November 2000

Cervical cancer screening in Germany

  • U Schenck

      Affiliations

    • Labor für Klinische Zytologie, Institut für Allgemeine Pathologie and Pathologische Anatomie, TU München and Cytological Institute of the Bavarian Cancer Society, Postbox 800 411, 81 604 Munich, Germany
  • ,
  • L von Karsa

      Affiliations

    • Mammographie-Screening Planungsstelle, Zentralinstitut für die Kassenärztliche Versorgung in der Bundesrepublik Deutschland, Höninger Weg 115, 50969 Cologne, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 221 4005130; fax: +49 221 40057144

Received 12 April 2000; received in revised form 31 July 2000; accepted 3 August 2000.

Abstract 

Cervical cancer is one of the target cancers covered by the statutory German cancer screening programme which was introduced in West Germany in 1971 and expanded to the eastern part of the country in 1991. Women covered by statutory health insurance (over 90% of the female population) are eligible to receive an annual cervical examination including a Papanicolaou (PAP) smear beginning at age 20 years. Annual uptake currently slightly exceeds 50% of the eligible population. Shortly after implementation of the national screening programme in the early 1970s the incidence of invasive cervical cancer decreased moderately and the incidence of cervical carcinoma in situ increased substantially in the state of Saarland. These observations would be expected as a result of a cervical cancer screening programme with substantial uptake. Although quality assurance guidelines for cervical cancer screening have been adopted and updated since the inception of the screening programme, only minor changes have been made in the cross-sectional programme documentation. Implementation of population-based documentation and evaluation of screening activities is currently being developed for the German cancer screening programme in pilot studies implementing the European guidelines on the quality assurance of mammography screening. After demonstration of feasibility and effectiveness, improvements in the quality management of breast cancer screening will subsequently be applied to the cervical cancer screening programme.

Keywords:  Germany, Cervical cancer screening, Organised

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(00)00313-0

European Journal of Cancer
Volume 36, Issue 17 , Pages 2221-2226, November 2000